Literature DB >> 29462673

Heterotopic ossification and lessons learned from fifteen years at war: A review of therapy, novel research, and future directions for military and civilian orthopaedic trauma.

Benjamin W Hoyt1, Gabriel J Pavey1, Benjamin K Potter1, Jonathan A Forsberg2.   

Abstract

Heterotopic ossification, the formation of bone in soft tissues, is a common complication of the high-energy extremity trauma sustained in modern armed conflict. In the past 15years, military treatment facilities and aligned laboratories have been in a unique position to study and treat this process due to the high volume of patients with these injuries secondary to blast trauma. The devastating nature of these wounds has limited traditional therapeutic options, necessitating alternative solutions to prophylaxis and initial treatment producing substantial advances in modeling, prophylaxis, detection, and therapy. Specific developments include establishment of an animal model that reproduces the systemic and local tissue injury of blast injuries, the use of molecular assays and predictive modeling in clinical decision making, advances in early detection including Raman spectroscopy, and investigation of prophylactic and therapeutic pharmacotherapy targeting the molecular pathways of aberrant bone formation. In this review article, we will present the literature to date, ongoing studies, and future directions for investigation of heterotopic ossification, with a focus on military-specific research.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Animal model; Blast injuries; Early detection; Heterotopic ossification; Primary prophylaxis; Surgical excision

Mesh:

Year:  2018        PMID: 29462673     DOI: 10.1016/j.bone.2018.02.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Union Rates and Reported Range of Motion Are Acceptable After Open Forearm Fractures in Military Combatants.

Authors:  Kyle E Nappo; Benjamin W Hoyt; George C Balazs; George P Nanos; Derek F Ipsen; Scott M Tintle; Elizabeth M Polfer
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

Review 2.  Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies.

Authors:  Ker Rui Wong; Richelle Mychasiuk; Terence J O'Brien; Sandy R Shultz; Stuart J McDonald; Rhys D Brady
Journal:  Bone Res       Date:  2020-12-09       Impact factor: 13.567

3.  The Kinesin Gene KIF26B Modulates the Severity of Post-Traumatic Heterotopic Ossification.

Authors:  George A E Pickering; Favour Felix-Ilemhenbhio; Matthew J Clark; Klaudia Kocsy; Jonathan Simpson; Ilaria Bellantuono; Alison Gartland; Jeremy Mark Wilkinson; Konstantinos Hatzikotoulas; Endre Kiss-Toth
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

Review 4.  The War after War: Volumetric Muscle Loss Incidence, Implication, Current Therapies and Emerging Reconstructive Strategies, a Comprehensive Review.

Authors:  Stefano Testa; Ersilia Fornetti; Claudia Fuoco; Carles Sanchez-Riera; Francesco Rizzo; Mario Ciccotti; Stefano Cannata; Tommaso Sciarra; Cesare Gargioli
Journal:  Biomedicines       Date:  2021-05-18

5.  Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway.

Authors:  Dali Zhang; Junlan Huang; Xianding Sun; Hangang Chen; Shuo Huang; Jing Yang; Xiaolan Du; Qiaoyan Tan; Fengtao Luo; Ruobin Zhang; Siru Zhou; Wanling Jiang; Zhenhong Ni; Zuqiang Wang; Min Jin; Meng Xu; Fangfang Li; Liang Chen; Mi Liu; Nan Su; Xiaoqing Luo; Liangjun Yin; Ying Zhu; Jerry Q Feng; Di Chen; Huabing Qi; Lin Chen; Yangli Xie
Journal:  Nat Commun       Date:  2021-07-19       Impact factor: 14.919

Review 6.  Cellular plasticity, caspases and autophagy; that which does not kill us, well, makes us different.

Authors:  Tin Tin Su
Journal:  Open Biol       Date:  2018-11-28       Impact factor: 6.411

Review 7.  Mechanism of traumatic heterotopic ossification: In search of injury-induced osteogenic factors.

Authors:  Rocky S Tuan
Journal:  J Cell Mol Med       Date:  2020-08-27       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.